Tecomedical
Environmental assays
Assay Services
(Pre) Clincial studies
Prevention
Biomarker assays
Biosafety
Custom assay development
Diagnosis
Disease Control
Toxicology
Monitoring
Drug Development
Specialty Assays
Company profile
Therapy
·· Fish assays for substances with endocrine disrupting potential ·· Detection of substances with estrogenic activities ·· First assay allowing non-destructive, non-invasive sampling from epidermal mucosa ·· Detection of Vitellogenin in blood, homogenates and mucus ·· Applications in ecotoxicological monitoring programmes ·· Efficiency control of sewage plants ·· REACH Vitellogenin ELISA: Specially designed assays for chemical testing according to OECD Guidelines (229, 230, 234) and EC regulation Nr. 440/2008 (REACH) from July 10th 2015 ·· Water assays for chemical substances
Education
Founded in 1984, the Swiss-based TECOmedical Group and the subsidiaries in Germany, France, Austria and Benelux provide assays and services for (pre)clinical studies, biosafety and toxicology studies, medical research and in vitro diagnostics. We offer an extensive portfolio of speciality assays, assay systems and services to Pharma and Biotech companies, CROs, medical and research centres. With our speciality assays and custom assay development we support the entire development cycle of new therapeutic agents; from basic research in cell cultures (mono and 3-D) to animal models and from (pre-)clinical studies to therapy monitoring. To offer an extensive portfolio of speciality assays, we work closely together with leading manufacturers. Speciality ELISA assays are also developed by our own R&D department in Germany.
7 th european biotechnology guide 2017
152 | 153